Vanesa Gregorc

7.8k total citations
136 papers, 3.4k citations indexed

About

Vanesa Gregorc is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Vanesa Gregorc has authored 136 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Oncology, 80 papers in Pulmonary and Respiratory Medicine and 28 papers in Molecular Biology. Recurrent topics in Vanesa Gregorc's work include Lung Cancer Treatments and Mutations (64 papers), Lung Cancer Research Studies (43 papers) and Peptidase Inhibition and Analysis (26 papers). Vanesa Gregorc is often cited by papers focused on Lung Cancer Treatments and Mutations (64 papers), Lung Cancer Research Studies (43 papers) and Peptidase Inhibition and Analysis (26 papers). Vanesa Gregorc collaborates with scholars based in Italy, United States and Spain. Vanesa Gregorc's co-authors include Giovanni Luca Ceresoli, Lucio Crinò, Federico Cappuzzo, Stefania Bartolini, Chiara Lazzari, Vienna Ludovini, Anna Spreafico, Emmanuel Villa, Elisa Rossi and Alessandra Bulotta and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Vanesa Gregorc

132 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vanesa Gregorc Italy	33	2.2k	2.0k	1.1k	477	265	136	3.4k
Misako Nagasaka United States	31	1.9k 0.9×	1.8k 0.9×	1.2k 1.1×	646 1.4×	253 1.0×	205	3.2k
Francisco Robert United States	28	1.8k 0.8×	1.4k 0.7×	1.1k 1.0×	312 0.7×	290 1.1×	107	3.2k
Alessandro Russo Italy	31	1.5k 0.7×	1.4k 0.7×	872 0.8×	840 1.8×	235 0.9×	125	2.7k
Jonathan W. Riess United States	26	2.4k 1.1×	2.0k 1.0×	1.4k 1.3×	733 1.5×	171 0.6×	164	4.2k
Kenichi Suda Japan	35	2.5k 1.2×	2.8k 1.4×	1.7k 1.6×	890 1.9×	219 0.8×	130	4.3k
Luigi De Petris Sweden	24	1.2k 0.6×	1.6k 0.8×	697 0.6×	412 0.9×	368 1.4×	81	2.5k
Ignacio Gil‐Bazo Spain	31	1.1k 0.5×	1.0k 0.5×	1.2k 1.1×	805 1.7×	154 0.6×	103	2.6k
Sarah B. Goldberg United States	33	3.0k 1.4×	2.7k 1.3×	1.3k 1.2×	611 1.3×	215 0.8×	143	4.8k
Michael Millward Australia	25	1.7k 0.8×	1.1k 0.6×	1.1k 1.1×	331 0.7×	142 0.5×	43	2.9k
Ferdinandos Skoulidis United States	22	1.8k 0.8×	1.4k 0.7×	1.4k 1.3×	729 1.5×	135 0.5×	73	3.1k

Countries citing papers authored by Vanesa Gregorc

Since Specialization

Citations

This map shows the geographic impact of Vanesa Gregorc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanesa Gregorc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanesa Gregorc more than expected).

Fields of papers citing papers by Vanesa Gregorc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanesa Gregorc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanesa Gregorc. The network helps show where Vanesa Gregorc may publish in the future.

Co-authorship network of co-authors of Vanesa Gregorc

This figure shows the co-authorship network connecting the top 25 collaborators of Vanesa Gregorc. A scholar is included among the top collaborators of Vanesa Gregorc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanesa Gregorc. Vanesa Gregorc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Majem, Margarita, Vanesa Gregorc, Giuseppe Lo Russo, et al.. (2025). LBA1: First-line (1L) fulzerasib + cetuximab in KRAS G12Cm advanced NSCLC: Updated efficacy and safety from KROCUS study. Journal of Thoracic Oncology. 20(3). S1–S1.

Schram, Alison M., Gilberto Lopes, Elisa Fontana, et al.. (2024). 691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation. Annals of Oncology. 35. S535–S536. 2 indexed citations

Lupia, Tommaso, Elena Crisà, Giacomo Stroffolini, et al.. (2024). Presumptive pulmonary toxocariasis in a patient affected by acute myeloid leukemia and Hodgkin lymphoma: case report and review of the literature in immunocompromised hosts. Infezioni in Medicina. 32(1). 103–112. 1 indexed citations

Gregorc, Vanesa, María González‐Cao, Stefania Salvagni, et al.. (2024). KROCUS: A phase II study investigating the efficacy and safety of fulzerasib (GFH925) in combination with cetuximab in patients with previously untreated advanced KRAS G12C mutated NSCLC.. Journal of Clinical Oncology. 42(17_suppl). LBA8511–LBA8511. 14 indexed citations

Bartolini, Alice, Daniela Cantarella, Annamaria Gullà, et al.. (2024). Single-Nuclei Transcriptome Profiling Reveals Intra-Tumoral Heterogeneity and Characterizes Tumor Microenvironment Architecture in a Murine Melanoma Model. International Journal of Molecular Sciences. 25(20). 11228–11228.

Lu, Shun, Fabrice Barlési, Robert M. Jotte, et al.. (2024). OA09.06 Health-Related Quality of Life (HRQoL) Outcomes with Adagrasib vs Docetaxel in KRASG12C-Mutated Advanced NSCLC in KRYSTAL-12. Journal of Thoracic Oncology. 19(10). S30–S30. 2 indexed citations

Porcu, Luca, Leone Giordano, Stefano Cascinu, et al.. (2023). Emergency Department Visits among Cancer Patients during SARS-CoV-2 Pandemic. Cancers. 15(4). 1240–1240.

Lupia, Tommaso, Elena Crisà, Fabrizio Carnevale‐Schianca, et al.. (2023). Overlapping Infection by Strongyloides spp. and Cytomegalovirus in the Immunocompromised Host: A Comprehensive Review of the Literature. Tropical Medicine and Infectious Disease. 8(7). 358–358. 3 indexed citations

Galizia, Danilo, Sadatsugu Minei, Ange Polidori, et al.. (2023). 863P Microbiota and cytokines profile in patients (pts) affected by recurrent metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs) +/- chemotherapy (CT) and prebiotic inulin in the PRINCESS study. Annals of Oncology. 34. S560–S560.

10.

Pecciarini, Lorenza, Emanuela Brunetto, Greta Grassini, et al.. (2023). Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?. Cells. 12(8). 1135–1135. 12 indexed citations

11.

Lupia, Tommaso, Tiziano Allice, Vanesa Gregorc, et al.. (2023). Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series. Antibiotics. 12(9). 1460–1460. 9 indexed citations

12.

Gagliardi, Filippo, Silvia Snider, Lina Raffaella Barzaghi, et al.. (2021). Role of stereotactic radiosurgery for the treatment of brain metastasis in the era of immunotherapy: A systematic review on current evidences and predicting factors. Critical Reviews in Oncology/Hematology. 165. 103431–103431. 13 indexed citations

13.

Novellis, Pierluigi, Fabrizio Monaco, Giovanni Landoni, et al.. (2021). Venoarterial Extracorporeal Membrane Oxygenation Support in Lung Cancer Resection. The Annals of Thoracic Surgery. 113(3). e191–e193. 8 indexed citations

14.

Mirabile, Aurora, Leone Giordano, Gianluigi Arrigoni, et al.. (2020). Uncommon Site of Metastasis and Prolonged Survival in Patients with Anaplastic Thyroid Carcinoma: A Systematic Review of the Literature. Cancers. 12(9). 2585–2585. 4 indexed citations

15.

Paolino, Giovanni, Riccardo Pampena, Caterina Longo, et al.. (2020). Clinicopathological and dermoscopic features of amelanotic and hypomelanotic melanoma: a retrospective multicentric study. International Journal of Dermatology. 59(11). 1371–1380. 8 indexed citations

16.

Mirabile, Aurora, Licia Rivoltini, Elena Daveri, et al.. (2020). Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence. Cancers. 12(5). 1153–1153. 4 indexed citations

17.

Carretta, Angelo, Alessandro Bandiera, Piergiorgio Muriana, et al.. (2020). Prognostic role of positron emission tomography and computed tomography parameters in stage I lung adenocarcinoma. Radiology and Oncology. 54(3). 278–284. 6 indexed citations

18.

Gridelli, Cesare, E. Kaukel, Vanesa Gregorc, et al.. (2007). Single-Agent Pemetrexed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase II Trial. Journal of Thoracic Oncology. 2(3). 221–229. 35 indexed citations

19.

Gregorc, Vanesa, Giovanni Luca Ceresoli, Irene Floriani, et al.. (2004). Effects of Gefitinib on Serum Epidermal Growth Factor Receptor and HER2 in Patients with Advanced Non-Small Cell Lung Cancer. Clinical Cancer Research. 10(18). 6006–6012. 37 indexed citations

20.

Cappuzzo, Federico, Vanesa Gregorc, Elisa Rossi, et al.. (2003). Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC. Journal of Clinical Oncology. 21(14). 2658–2663. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact